Suchergebnisse - "Frigault, Matthew J"

PubPharm (35)

1

Stealth transgenes enable CAR-T cells to evade host immune responses

enthalten in: Journal for immunotherapy of cancer | 2024

von Grauwet, K. | Berger, T. | Kann, M. | +10

2

Automated detection of immune effector cell-associated neurotoxicity syndrome via quantitative EEG

enthalten in: Annals of clinical and translational neurology | 2023

von Eckhardt, C. | Sun, H. | Malik, P. | +17

3

Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome

enthalten in: Transplantation and cellular therapy | 2023

von Hines, M. | Knight, T. | McNerney, K. | +28

4

Paving the Road for Chimeric Antigen Receptor T Cells : American Society for Transplantation and Cellular Therapy 80/20 Task Force Consensus on Challenges and Solutions to Improving Efficiency of Clinical Center Certification and Maintenance of Operations for Commercially Approved Immune Effector Cell Therapies

enthalten in: Transplantation and cellular therapy | 2023

von Nikiforow, S. | Frigault, M. | Frey, N. | +14

5

Perception of prognosis, quality of life, and distress in patients receiving chimeric antigen receptor T-cell therapy

enthalten in: Cancer | 2023

von Dhawale, T. | Johnson, P. | Gaballa, M. | +6

6

Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma

enthalten in: Nature medicine | 2022

von Haradhvala, N. | Leick, M. | Maurer, K. | +24

CommentIn: Nat Med. 2022 Sep;28(9):1755-1756. - PMID 36109644

7

Non-cleavable hinge enhances avidity and expansion of CAR-T cells for acute myeloid leukemia

enthalten in: Cancer cell | 2022

von Leick, M. | Silva, H. | Scarfò, I. | +13

CommentIn: Cell Rep Med. 2022 May 17;3(5):100639. - PMID 35584621

8

Blockade or Deletion of IFNγ Reduces Macrophage Activation without Compromising CAR T-cell Function in Hematologic Malignancies

enthalten in: Blood cancer discovery | 2022

von Bailey, S. | Vatsa, S. | Larson, R. | +13

CommentIn: Blood Cancer Discov. 2022 Mar 1;3(2):90-94. - PMID 35015687

9

Single-center experience using anakinra for steroid-refractory immune effector cell-associated neurotoxicity syndrome (ICANS)

enthalten in: Journal for immunotherapy of cancer | 2022

von Wehrli, M. | Gallagher, K. | Chen, Y. | +13

10

Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10+ advanced non-small cell lung cancer

enthalten in: Journal for immunotherapy of cancer | 2022

von Blumenschein, G. | Devarakonda, S. | Johnson, M. | +24